Proteomics, Metabolomics and Lipidomics News and Research

Latest Proteomics, Metabolomics and Lipidomics News and Research

Non-neutralizing antibodies likely to protect against COVID, says study

Non-neutralizing antibodies likely to protect against COVID, says study

20 Jan 2022
Researchers discover a key mechanism used by Zika virus to evade cell’s antiviral response

Researchers discover a key mechanism used by Zika virus to evade cell’s antiviral response

19 Jan 2022
New discovery offers insight into how cells maintain the integrity of DNA

New discovery offers insight into how cells maintain the integrity of DNA

19 Jan 2022
Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

From TetraScience, Inc. 18 Jan 2022
New finding could lead to the development of cell death regulators for cancer therapies

New finding could lead to the development of cell death regulators for cancer therapies

17 Jan 2022
Researchers discover a gene variant that protects against severe COVID-19 infection

Researchers discover a gene variant that protects against severe COVID-19 infection

17 Jan 2022
Risk linked to coronary arteriosclerosis may be explained by changes in gene networks

Risk linked to coronary arteriosclerosis may be explained by changes in gene networks

17 Jan 2022
Researchers identify new potential drug target that may block SARS-CoV-2 infection

Researchers identify new potential drug target that may block SARS-CoV-2 infection

17 Jan 2022
Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

14 Jan 2022
Changes in the activity of gene networks may explain arteriosclerosis risk

Changes in the activity of gene networks may explain arteriosclerosis risk

13 Jan 2022
First molecular images of enzyme may help solve the mystery cause of hereditary neurodegenerative diseases

First molecular images of enzyme may help solve the mystery cause of hereditary neurodegenerative diseases

From Walter and Eliza Hall Institute of Medical Research (WEHI) 13 Jan 2022
Research sheds new insights into development of lung macrophages in humans

Research sheds new insights into development of lung macrophages in humans

13 Jan 2022
Targeting the inflamed intestinal wall may be a novel way to prevent inflammation in HIV patients

Targeting the inflamed intestinal wall may be a novel way to prevent inflammation in HIV patients

13 Jan 2022
WVU food science experts determine the properties of protein in several insect powders

WVU food science experts determine the properties of protein in several insect powders

13 Jan 2022
Using E.Coli to bring 3D Printing to Life

Using E.Coli to bring 3D Printing to Life

From Massachusetts Institute of Technology (MIT) 13 Jan 2022
The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company Expands Range of Norovirus-Like Particles

From The Native Antigen Company 13 Jan 2022
Novel research sheds light on the genetic pathways underlying obesity

Novel research sheds light on the genetic pathways underlying obesity

13 Jan 2022
Experts develop CRISPR-Cas9-mediated inheritance control in male mice

Experts develop CRISPR-Cas9-mediated inheritance control in male mice

From UC San Diego 13 Jan 2022
Experts develop AI-based binding site detection in nucleic acid macromolecules

Experts develop AI-based binding site detection in nucleic acid macromolecules

13 Jan 2022
Study analyzes the impact of T cells from common cold coronaviruses against SARS-CoV-2 exposure

Study analyzes the impact of T cells from common cold coronaviruses against SARS-CoV-2 exposure

13 Jan 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback